Knight Therapeutics Inc opened trading today at $5.90 and closed at $5.79. It traded at a low of $5.76 to a high of $5.94.

Share prices eased -1.19% from the previous day's close of $5.86.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 75,589 shares was traded during the last trading day, with total trades of 312, while having an average volume of 62,316 in the last five days.

Trading across the entire TSX saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 20.88% in 52 weeks, while they have advanced 11.56% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $592.86 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..